Epidemiology of psychiatric symptoms in Parkinson's disease

Advances in Biological Psychiatry

Volumn 27, Issue , 2012, Pages 1-12

  Leentjens, Albert F G ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870262986     PISSN: 03787354     EISSN: 16622774     Source Type: Book Series    
DOI: 10.1159/000331522     Document Type: Article

References (112)

1. De Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MMB, Maraganore DM: A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997;48:1277-1281.
2. Wolters EC, Bosbaan JLW: Parkinson's disease; in Wolters EC, Van Laar T, Berendse HW (eds): Parkinsonism and Related Disorders. Amsterdam, VU University Press 2007, pp 143-158.
3. van Rooden SM, Colas F, Martinez-Martin P, Visser M, Verbaan D, Marinus J, Chaudhuri RK, Kok JN, van Hilten JJ: Clinical subtypes of Parkinson's disease. Mov Disord 2010;25:969-978.
4. Reijnders JSAM, Ehrt U, Lousberg R, Aarsland D, Leentjens AFG: The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism Relat Disord 2008;15:379-382.
5. Braak H, Del Treci K, Rub U, De Vos RAI, Jansen Steur ENH, Braak E: Staging brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
6. Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG: A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008;23:183-189.
7. Holroyd S, Currie LJ, Wooten GF: Depression is associated with impairment of ADL, not motor function in Parkinson's disease. Neurology 2005;64: 2134-2135.
8. Ravina B, Camiciolli R, Como PG, Marsh L, Jankovic J, Weintraub D, Elm J: The impact of depressive symptoms in Parkinson's disease. Neurology 2007;69:342-347.
9. Schrag A, Jahanshahi M, Quinn N: What contributes to quality of life in Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
10. Liu CY, Wang SJ, Fuh JL, Lin CH, Yang YY, Liu HC: The correlation of depression with functional ability in Parkinson's disease. J Neurol 1997;244:493-498.
11. Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC: Neuropsycholological impairment in Parkinson's disease with and without depression. Arch Neurol 1995;52:1164-1169.
12. Santangelo G, Vitale C, Trojano L, Longo K, Cozzolino A, Grossi D, Barone P: Relationship between depression and cognitive dysfunction in Parkinson's disease without dementia. J Neurol 2009;256:632-638.
13. Hobson P, Holden A, Meara J: Measuring the impact of Parkinson's disease with the Parkinson's disease quality of life questionnaire. Age Ageing 1999;28: 341-346.
14. Global Parkinson's Disease Survey Steering Committee: Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Mov Disord 2002;17:60-67.
15. Aarsland D: Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999;14:866-874.
16. Leentjens AFG, Lousberg R, Verhey FRJ: Markers for depression in Parkinson's disease. Acta Psychiatr Scand 2002;106:196-201.
17. Riedel O, Heuser I, Klotsche J, Dodel R, Wittchen HU, GEPAD Study Group: Occurrence risk and structure of depression in Parkinson disease with and without dementia: Results from the GEPAD study. J Geriatr Psychiatry Neurol 2010;23:27-34.
18. Tandberg E, Larsen JP, Aarsland D, Laake K, Cummings J: Risk factors for depression in Parkinson's disease. Arch Neurol 1997;54:625-630.
19. Schrag A, Jahanshahi M, Quinn NP: What contributes to depression in Parkinson's disease? Psychol Med 2001;31:65-73.
20. Negre-Pages L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lepine JP, Rascol O: On behalf of the DoPaMiP study group: Anxious and depressive symptoms in Parkinson's disease: The French cross-sectional DoPaMiP study. Mov Disord 2010;25:157-166.
21. Cole SA, Woodard JL, Juncos JL, Kogos JL, Youngstrom EA, Watts RL: Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1996;8:20-25.
22. Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG: Depression in Parkinson's disease. J Nerv Ment Dis 1990;178:27-31.
23. Tandberg E, Larsen JP, Aarsland D, Cummings JL: The occurrence of depression in Parkinson's disease; a community based study. Arch Neurol 1996;53:175-179.
24. Barone P, Poewe W, Albrecht S, Debieuvre A, Massey D, Rascol O, Tolosa E, Weintraub D: Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: A randomised, double blind, placebo controlled trial. Lancet Neurol 2010;9:573-580.
25. Leentjens AFG, Koester J, Fruh B, Shephard DTS, Barone P, Houben J: The effect of treatment with pramipexole on mood and motivational symptoms in Parkinson's disease: A meta-analysis of placebo controlled studies. Clin Ther 2009;31:98-98, erratum in Clin Ther 2009;2031:2677.
26. Fleminger S: Left-sided Parkinson's disease is associated with greater anxiety and depression. Psychol Med 1991;21:629-638.
27. Ishihara L, Brayne C: A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 2006;113:211-220.
28. Nilsson FM, Kessing LV, Bolwig TG: Increased risk of developing Parkinson's disease for patients with major affective disorder: A register study. Acta Psychiatr Scand 2001;104:380-386.
29. Schuurman AG, Van den Akker M, Ensinck KTJL, Metsemakers JFM, Knottnerus JA, Leentjens AFG, Buntinx F: Increased risk of Parkinson's disease after depression: A retrospective cohort study. Neurology 2002;58:1501-1504.
30. Leentjens AFG, Van den Akker M, Metsemakers JFM, Lousberg R, Verhey FR: Higher incidence of depression preceding the onset of Parkinson's disease: A register study. Mov Disord 2003;18:414-418.
31. Dissanayaka NN, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD: Anxiety disorders in Parkinson's disease: Prevalence and risk factors. Mov Disord 2010;15:7.
32. Leentjens AFG, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P: Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross-sectional study. Mov Disord 2011;26: 484-492.
33. Menza MA, Robertson-Hoffman DE, Banapace AS: Parkinson's disease and anxiety: Comorbidity with depression. Biol Psychiatry 1993;34:465-470.
34. Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L: Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord 2009;24:1333-1338.
35. Richard IH: Anxiety disorders in Parkinson's disease. Adv Neurol 2005;96:42-55.
36. Lauterbach EC, Freeman A, Vogel RL: Correlates of generalized anxiety and panic attacks in dystonia and Parkinson's disease. Cogn Behav Neurol 2003; 16:225-233.
37. Siemers ER, Shekhar A, Quaid K, Dickson H: Anxiety and motor performance in Parkinson's disease. Mov Disord 1993;8:501-506.
38. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P, Garcia-Urra D: 'Panic attacks' in Parkinson's disease; a long-term complication of levodopatherapy. Acta Neurol Scand 1993;87:14-18.
39. Marinus J, Leentjens AFG, Visser M, Stiggelbout AM, Van Hilten JJ: Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol 2002;6:318-324.
40. Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA: Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study. Mov Disord 2000;15:669-677.
41. Marin RS: Apathy, a neuropsychiatric syndrome. J Neurol Neurosurg Psychiatry 1991;3:243-254.
42. Starkstein SE: Apathy and withdrawal. Int Psychogeriatr 2000;12(suppl 1):135-138.
43. Starkstein SE, Merello M, Jorge R, Brockman S, Bruce D, Power B: The syndromal validity and nosological position of apathy in Parkinson's disease. Mov Disord 2009;24:1211-1216.
44. Robert P, Onyike CU, Leentjens AFG, Dujardin K, Aalten P, Starkstein SE, Verhey FRJ, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Thibaut F, Gauthier S, Grossberg G, Vellas B, Byrne J: Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 2009;66:531-535.
45. Drijgers RL, Dujardin K, Reijnders JSAM, Defebvre L, Leentjens AFG: Validation of diagnostic criteria for apathy in Parkinson's disease. Parkinsonism Relat Disord 2010;16:656-660.
46. Mulin E, Leone E, Dujardin K, Delliaux M, Leentjens AFG, Nobili F, Dessi B, Tible O, Aguera-Ortiz L, Osorio RS, Yessavage J, Dachevsky D, Verhey FRJ, Jentoft AJ, Blanc O, Llorca PM, Robert PH: Diagnostic criteria for apathy in clinical practice. Int J Geriatr Psychiatry 2011;26:158-165.
47. Dujardin K, Sockeel P, Devos D, Delliaux M, Krystkowiak P, Destee A, Defebvre L: Characteristics of apathy in Parkinson's disease. Mov Disord 2007; 22:778-784.
48. Pluck GC, Brown RG: Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:636- 642.
49. Oguru M, Tachibana H, Toda K, Okuda B, Oka N: Apathy and depression in Parkinson disease. J Geriatr Psychiatry Neurol 2010;23:35-41.
50. Pedersen KF, Alves G, Aarsland D, Larsen JP: Occurrence and risk factors for apathy in Parkinson disease: A 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 2009;80:1279-1282.
51. Fenelon G, Mahieux F, Huon R, Ziegler M: Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors. Brain 2000;123: 733-745.
52. Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D, Alves G: A 12-year population- based study of psychosis in Parkinson disease. Arch Neurol 2010;66:996-1001.
53. Goetz CG: Hallucinations in Parkinson's disease: The clinical syndrome. Adv Neurol 1999;80:419-423.
54. Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB: Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 2001;57: 2078-2082.
55. Goetz C, Stebbins GT: Hallucinations and sleep disorders in Parkinson's disease: Six year prospective longitudinal study. Neurology 2005;64:81-86.
56. de Maindreville AD, Fenelon G, Mahieux F: Hallucinations in Parkinson's disease: A follow-up study. Mov Disord 2005;20:212-217.
57. Rajput AH, Offord KP, Beard CM, Kurland LT: A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology 1987;37:226-232.
58. Aarsland D, Larsen JP, Tandberg E, Laake K: Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study. J Am Geriatr Soc 2000;48:938-942.
59. Goetz CG, Stebbins GT: Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-2229.
60. McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson T, Fink J, Roger D: A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia. Parkinsonism Relat Disord 2008;14:37-42.
61. Fenelon G, Goetz CG, Karenberg A: Hallucinations in Parkinson disease in the prelevodopa era. Neurology 2006;66:93-98.
62. Goetz CG, Pappert EJ, Blasucci LM, Stebbins GT, Ling ZD, Nora MV, Carvey PM: Intravenous levodopa in hallucinating Parkinson's disease patients: High-dose challenge does not precipitate hallucinations. Neurology 1998;50:515-517.
63. Aarsland D, Larsen JP, Cummings JL, Laake K: Prevalence and clinical correlates of psychotic symptoms in Parkinson disease. A communitybased study. Arch Neurol 1999;56:595-601.
64. Klein C, Kompf D, Pulkowski U, Moser A, Vieregge P: A study of visual hallucinations in patients with Parkinson's disease. J Neurol 1997;244:371-377.
65. Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V: Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 1998;21:289-295.
66. Sanches-Ramos JR, Ortoll R, Paulson GW: Visual hallucinations associated with Parkinson's disease. Arch Neurol 1996;53:1265-1268.
67. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ: Sleep disorders and sleep effect in Parkison's disease. Mov Disord 1990;5:280-285.
68. Comella CL: Sleep disorders in Parkinson's disease: An overview. Mov Disord 2007;22(suppl 17): S367-S373.
69. Menza M, DeFronzo Dobkin R, Marin H, Bienfait K: Sleep disturbances in Parkinson's disease. Mov Disord 2010;25(suppl 1):S117-S122.
70. Gagnon JF, Bedard MA, Fantini ML, Petit D, Panisset M, Rompre S, Carrier J, Montplaisier J: REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002;59:585-589.
71. Onofrj M, Thomas A, D'Andreamatteo G, Iacono D, Luciano AL, Di Rollo A, Di Mascio R, Ballone E, Di Iorio A: Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow- up. J Neurol Sci 2002;23(suppl 2):S91-S94.
72. Pacchetti C, Manni R, Zangaglia R, Mancini F, Marchioni E, Tassorelli C, Terzaghi M, Ossola M, Martignoni E, Moglia A, Nappi G: Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 2005;20:1439-1448.
73. Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J: Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001;57: 1392-1396.
74. Tandberg E, Larsen JP, Karlsen K: Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community-based study. Mov Disord 1999;14:922- 927.
75. Homann CN, Wenzel K, Suppan K, Ivanic G, Crevenna R, Ott E: Sleep attacks - facts and fiction: A critical review. Adv Neurol 2003;91:335-341.
76. Oerlemans WG, de Weerd AW: The prevalence of sleep disorders in patients with Parkinson's disease: A self-reported community-based survey. Sleep Med 2002;3:147-149.
77. Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, Schlesser M: Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Mov Disord 2005;20:1413-1418.
78. Wetter TC, Collado-Seidel V, Pollmacher T, Yassouridis A, Trenkwalder C: Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000;23:361-367.
79. Tan EK, Lum SY, Wong MC: Restless legs syndrome in Parkinson's disease. J Neurol Sci 2002;196:33-36.
80. Ondo WG, Vuong KD, Jankovic J: Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59:421-414.
81. Karlsen KH, Tandberg E, Aarsland D, Larsen JP: Health related quality of life in Parkinson's disease: A prospective longitudinal study. J Neurol Neurosurg Psychiatry 2000;69:584-589.
82. Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F: Health-related quality of life and sleep disorders in Parkinson's disease. Neurol Sci 2003;24: 209-210.
83. Gjerstad MD, Aarsland D, Larsen JP: Development of daytime somnolence over time in Parkinson's disease. Neurology 2002;58:1544-1546.
84. Marion MH, Qurashi M, Marshall G, Foster O: Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?J Neurol 2008;255:192-196.
85. Happe S, Berger K: FAQT Study Investigators: The association between caregiver burden and sleep disturbances in partners of patients with Parkinson's disease. Age Ageing 2002;31:349-354.
86. Pal PK, Thennarasu K, Fleming J, Schulzer M, Brown T, Calne SM: Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers. Parkinsonism Relat Disord 2004;10:157-168.
87. Smith MC, Ellgring H, Oertel WH: Sleep disturbances in Parkinson's disease patients and spouses. J Am Geriatr Soc 1997;45:194-199.
88. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J: Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006;67:1254-1257.
89. Koller WC, Vetere-Overfield B, Williamson A, Busenbark K, Nash J, Parrish D: Sexual dysfunction in Parkinson's disease. Clin Neuropharmacol 1990; 13:461-463.
90. Brown RG, Jahanshahi M, Quinn N, Marsden CD: Sexual functions in patients with Parkinson's disease and their partners. J Neurol Neurosurg Psychiatry 1990;53:480-486.
91. Pfeiffer RF: Gastrointestinal, urological and sexual dysfunction in Parkinson's disease. Mov Disord 2010;25(suppl 1):S94-S97.
92. Sakakibara R, Shinotoh H, Uchiyama T, Sakuma M, Kashiwado M, Yoshiyama M, Hattori T: Questionnaire- based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001;17: 76-85.
93. Waters C, Smolowitz J: Impaired sexual function; in Pfeiffer RF, Bodis-Wollner I (eds): Parkinson's Disease and Non-Motor Function. Totowa, Humana Press 2005, pp 127-137.
94. Okun MS, Walter BL, McDonald WM, Tenover JL, Green J, Juncos JL, DeLong MR: Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson's disease. Arch Neurol 2002;59: 1750-1753.
95. Balami J, Robertson D: Parkinson's disease and sexuality. Br J Hosp Med 2007;68:644-647.
96. Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E: Chronic dopaminergic stimulation in Parkinson's disease: From dyskinesias to impulse control disorders. Lancet Neurol 2009;8:1140-1149.
97. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE: Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-595.
98. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB: Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969-973.
99. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F: Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006; 21:2068-2072.
100. Voon V, Fox SH: Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007;64:1089-1096.
101. Janvin CC, Larsen JP, Aarsland D, Hugdahl K: Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia. Mov Disord 2006;21:1342-1349.
102. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH: Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272- 1277.
103. Janvin C, Aarsland D, Larsen JP, Hugdahl K: Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003;15:126-131.
104. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA: Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130:1787-1798.
105. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B: Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
106. Aarsland D, Zaccai J, Brayne C: A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005;20:1255-1263.
107. Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RHS, Spokes EGS: A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000;54: 1596-1602.
108. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh- Sorensen P: Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Arch Neurol 2003;60:387-392.
109. Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D: Dementia and survival in Parkinson's disease: A 12-year population study. Neurology 2008;70:1017-1022.
110. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG: The Sydney Multicenter Study of Parkinson's Disease: The inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
111. Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU: Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol 2008;255:255-264.
112. Winter Y, von Campenhausen S, Popov G, Reese JP, Balzer-Geldsetzer M, Kukshina A, Zhukova TV, Bertschi N, Botzel K, Gusev E, Oertel WH, Dodel R, Guekht A: Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study. Parkinsonism Relat Disord 2010;16:243-248.